Video Description

Bleeding control algorithm when using MHT (CN)

Absolute MHT contraindications: Past diagnosis or suspicion of breast cancer. Diagnosed in the past or suspicion of estrogen-dependent malignant tumors (for example, endometrial cancer III, IV stage and poorly differentiated endometrial cancer). Established progestagen-dependent neoplasms (for example, meningioma) or suspicion of them. Vaginal bleeding of unknown origin. Untreated endometrial hyperplasia. Presence of VTE (deep vein…

Bleeding control algorithm when using MHT (UK)

Absolute MHT contraindications: Past diagnosis or suspicion of breast cancer. Diagnosed in the past or suspicion of estrogen-dependent malignant tumors (for example, endometrial cancer III, IV stage and poorly differentiated endometrial cancer). Established progestagen-dependent neoplasms (for example, meningioma) or suspicion of them. Vaginal bleeding of unknown origin. Untreated endometrial hyperplasia. Presence of VTE (deep vein…

Bleeding control algorithm when using MHT (ES)

Absolute MHT contraindications: Past diagnosis or suspicion of breast cancer. Diagnosed in the past or suspicion of estrogen-dependent malignant tumors (for example, endometrial cancer III, IV stage and poorly differentiated endometrial cancer). Established progestagen-dependent neoplasms (for example, meningioma) or suspicion of them. Vaginal bleeding of unknown origin. Untreated endometrial hyperplasia. Presence of VTE (deep vein…

Bleeding control algorithm when using MHT (PT)

Absolute MHT contraindications: Past diagnosis or suspicion of breast cancer. Diagnosed in the past or suspicion of estrogen-dependent malignant tumors (for example, endometrial cancer III, IV stage and poorly differentiated endometrial cancer). Established progestagen-dependent neoplasms (for example, meningioma) or suspicion of them. Vaginal bleeding of unknown origin. Untreated endometrial hyperplasia. Presence of VTE (deep vein…

Bleeding control algorithm when using MHT (EN)

Absolute MHT contraindications: Past diagnosis or suspicion of breast cancer. Diagnosed in the past or suspicion of estrogen-dependent malignant tumors (for example, endometrial cancer III, IV stage and poorly differentiated endometrial cancer). Established progestagen-dependent neoplasms (for example, meningioma) or suspicion of them. Vaginal bleeding of unknown origin. Untreated endometrial hyperplasia. Presence of VTE (deep vein…